Emyria locks in $2.3M to progress MDMA research – with Chair adding $0.3M
ASX-listed and WA-based Emyria Limited (ASX:EMD) has announced its successful receipt of…
Emyria Limited (ASX:EMD)
About Emyria Limited
Key Information
EMD In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 26/04/2024 | Price Sensitive PS March 2024 Quarterly Activities Report and Appendix 4C | 516.19KB | 3.5K |
| 23/04/2024 | Proposed issue of securities - EMD | 27.99KB | 163 |
| 23/04/2024 | Price Sensitive PS Emyria Receives Bids of $2.3M to Expand Clinical Services | 674.43KB | 230 |
| 19/04/2024 | Price Sensitive PS Trading Halt | 779.23KB | 3.8K |
| 10/04/2024 | Price Sensitive PS Emyria Opens Empax Centre to Advance Mental Health Care | 1.92MB | 1.3K |
| 05/04/2024 | Price Sensitive PS Emyria Expands Specialist AP Team - First Female for MDMA-AT | 449.97KB | 1.3K |
| 03/04/2024 | Price Sensitive PS Emyria, Reach Wellness Enter MDMA-AT Research Agreement | 688.66KB | 607 |
| 19/03/2024 | Notification of cessation of securities - EMD | 13.77KB | 309 |